Effect of nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen pretreatment in peripheral nerve allotransplantation

Microsurgery

Volumn 22, Issue 8, 2002, Pages 329-334

  Doolabh, Vaishali B ^a   Tung, Thomas H ^a   Flye, M Wayne ^a   Mackinnon, Susan E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b East Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RIB 5 2; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; MORBIDITY; NERVE GRAFT; NERVE REGENERATION; NERVE TRANSPLANTATION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; PERIPHERAL NERVES; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RATS; RATS, INBRED BN; RATS, INBRED BUF; RATS, INBRED LEW; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036941201     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10068     Document Type: Article

References (17)

1. Mackinnon SE, Hudson AR. Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 1992;90:696-699.
2. Mackinnon SE. Nerve allotransplantation following severe tibial nerve injury - A case report. Neurosurgery 1996;84:671-676.
3. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419-1429.
4. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Transplantation 1992;54:483-490.
5. Saitovitch D, Morris PJ, Wood KJ. Recipient cell expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-CD4 monoclonal antibody. Transplantation 1996;61:1532-158.
6. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts. Transplantation 1997;63:1490-1494.
7. Genden EM, Mackinnon SE, Yu S, Hunter DA, Flye MW. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts. Laryngoscope 2001;111:439-447.
8. Arima T, Lehmann M, Flye MW. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation 1997;63:284-292.
9. Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk H, Kupiec-Weglinski JW. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of rat cardiac allografts. Transplantation 1996;61:804-811.
10. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: Primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990;20:2747-2755.
11. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. Transplantation 1994;58:133-138.
12. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995;25:2643-2649.
13. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ. Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfu-sion before transplantation. Transplantation 1996;61:1642-1647.
14. Atchabahian A, Doolabh V, Mackinnon SE, Flye MW, Yu S, Hunter DA. Indefinite survival of peripheral nerve allografts after temporary cyclosporin A immunosuppression. Restor Neurol Neurosci 1998;13:129-139.
15. Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 1996;62:856-860.
16. Wood MJA, Sloan DJ, Wood KJ, Charlton HM. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies. Neuroscience 1996;70:775-789.
17. Lee M, Doolabh VB, Mackinnon SE, Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 2000;23:633-640.